Translational Development Acquisition Corp. Units (TDACU) Financials
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the TDACU SEC filings page.
This page shows Translational Development Acquisition Corp. Units (TDACU) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
The dominant mechanic is a liability-funded balance sheet with reported profit disconnected from operating cash generation.
In FY2025, net income reached$6.4M while operating cash flow remained-$608K ; the reversal indicates that reported profitability was not being converted into cash through operations. Compared with FY2024's-$71K net loss, the earnings swing therefore says less about operating progress than it might appear without identifying the accounting drivers.
FY2025 liabilities of
The current ratio fell from 3.1x in FY2024 to 0.1x in FY2025, indicating a sharp deterioration in short-term balance-sheet flexibility. Operating cash flow improved from
Financial Health Signals
Translational Development Acquisition Corp. Units does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Translational Development Acquisition Corp. Units passes 2 of 5 computable financial strength tests (4 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
For every $1 of reported earnings, Translational Development Acquisition Corp. Units used $0.10 of operating cash (-$608K OCF vs $6.4M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.
Key Financial Metrics
Earnings & Revenue
Translational Development Acquisition Corp. Units reported $947K in net income in Q2 2026. This represents a decrease of 41.7% from the same quarter a year earlier. Against the prior quarter it is down 28.9%.
Not reported for Q2 2026.
Not reported for Q2 2026.
Not reported for Q2 2026.
Cash & Balance Sheet
Translational Development Acquisition Corp. Units held $86K in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
None of these metrics is reported for Q2 2026.
Capital Allocation
None of these metrics is reported for Q2 2026.
TDACU Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| SG&A Expenses | $661K+198.9% | $281K-19.1% | N/A | $214K+248.6% | $221K+13023.3% | $347K | N/A | $61K |
| Operating Income | -$661K-198.9% | -$281K+19.1% | N/A | -$214K-248.6% | -$221K-13023.3% | -$347K | N/A | -$61K |
| Income Tax | N/A | $0 | N/A | N/A | N/A | $0 | N/A | N/A |
| Net Income | $947K-41.7% | $1.3M-10.1% | N/A | $1.7M+2808.9% | $1.6M+96440.8% | $1.5M | N/A | -$61K |
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, EBITDA, Interest Expense, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
TDACU Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $157.4M-11.7% | $183.3M+3.8% | $181.7M+3.8% | $180.0M | $178.2M | $176.6M | $175.0M+8659008.3% | N/A |
| Current Assets | $105K-32.9% | $75K-81.9% | $39K-93.9% | $81K | $156K | $415K | $650K+32073.8% | N/A |
| Cash & Equivalents | $86K+143.6% | $25K-88.1% | $30K-93.2% | $47K-79.0% | $35K-51.0% | $207K | $438K+21581.0% | $224K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $165.1M-10.5% | $190.2M+4.2% | $188.2M+4.2% | $186.4M | $184.3M | $182.5M | $180.6M+35333.7% | N/A |
| Current Liabilities | $1.8M+515.3% | $861K+166.7% | $544K+158.7% | $423K | $285K | $323K | $210K-58.7% | N/A |
| Non-Current Liabilities | $163.3M-11.3% | $189.3M+3.9% | $187.7M+4.1% | $185.9M | $184.1M | $182.2M | $180.4M | N/A |
| Total Equity | -$7.7M-24.6% | -$6.8M-14.8% | -$6.5M-16.9% | -$6.4M-1018.0% | -$6.2M-1110.6% | -$5.9M-1071.1% | -$5.6M-1002.6% | -$571K |
| Retained Earnings | -$7.7M-24.6% | -$6.8M-14.8% | -$6.5M-16.9% | -$6.4M | -$6.2M | -$5.9M | -$5.6M-951.0% | N/A |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
TDACU Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Dividends Paid, Share Buybacks.
TDACU Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Debt-to-Equity, Asset Turnover, FCF Margin.
Note: Shareholder equity is negative (-$6.5M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.07), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Translational Development Acquisition Corp. Units TDACU | FY2025 | N/A | $6.4M | N/A | N/A | — |
| Bold Eagle Acquisition Corp. Units BEAGU | FY2025 | N/A | $9.8M | N/A | N/A | — |
| Aldel Financial II Inc. Units ALDFU | FY2025 | N/A | $9.2M | N/A | N/A | — |
| Cayson Acquisition Corp Unit CAPNU | FY2025 | $4.9M | $3.0M | 62.0% | N/A | 24/100 |
| Charlton Aria Acquisition Corporation Units CHARU | FY2025 | N/A | $3.0M | N/A | N/A | — |
Where Translational Development Acquisition Corp. Units Ranks
Frequently Asked Questions
Is Translational Development Acquisition Corp. Units profitable?
Yes, Translational Development Acquisition Corp. Units (TDACU) reported a net income of $6.4M in fiscal year 2025.
What is Translational Development Acquisition Corp. Units's operating cash flow?
Translational Development Acquisition Corp. Units (TDACU) recorded an outflow of $608K in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Translational Development Acquisition Corp. Units's total assets?
Translational Development Acquisition Corp. Units (TDACU) had $181.7M in total assets as of fiscal year 2025, including both current and long-term assets.
What is Translational Development Acquisition Corp. Units's current ratio?
Translational Development Acquisition Corp. Units (TDACU) had a current ratio of 0.07 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Translational Development Acquisition Corp. Units's return on assets (ROA)?
Translational Development Acquisition Corp. Units (TDACU) had a return on assets of 3.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Why is Translational Development Acquisition Corp. Units's debt-to-equity ratio negative or not reported?
Translational Development Acquisition Corp. Units (TDACU) has negative shareholder equity of -$6.5M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Translational Development Acquisition Corp. Units's Piotroski F-Score?
Translational Development Acquisition Corp. Units (TDACU) has a Piotroski F-Score of 2 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Translational Development Acquisition Corp. Units's earnings high quality?
For every $1 of reported earnings, Translational Development Acquisition Corp. Units (TDACU) used $0.10 of operating cash (-$608K OCF vs $6.4M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.